Explore the latest in hidradenitis suppurativa, including advances in understanding the pathophysiology and treatment of the disorder.
This cohort study compares overall and subgroup incidence of long-term opioid use in a population of opioid-naive patients with hidradenitis suppurativa and controls from US electronic health record data.
This systematic review and meta-analysis investigates the associated risk of inflammatory bowel disease in patients with hidradenitis suppurativa.
This cohort study examines the median age at onset of hidradenitis suppurativa and compares age at onset across sex, race, and disease severity of individuals.
This systematic review and meta-analysis evaluates 10 observational studies to assess the prevalence of depression and anxiety in patients with hidradenitis suppurativa and the odds of these psychiatric disorders in this population.
This cross-sectional study investigates the standardized overall comorbidity burden among patients with hidradenitis suppurativa and compares it with the comorbidity burden in patients with psoriasis and a control group.
This cohort analysis evaluates the risk of lymphoma in adult patients with hydradenitis suppurativa in the United States.
This case-control study investigates the mesenchymal stem cell profile in patients with hidradenitis suppurativa and in healthy controls, with punch biopsy samples from axillary skin analyzed for immunophenotypic profiles.
This cohort analysis evaluates the association of low socioeconomic status with hidradenitis suppurativa among patients in the United States.
A woman in her 50s with a medical history of hypertension and depression was evaluated by the inpatient dermatology consult service for a 1.5-year history of painful intertriginous wounds; she was previously diagnosed with hidradenitis suppurativa. What is your diagnosis?
This case series uses semantic map analysis to assess the association of hidradenitis suppurativa with T helper 1/T helper 17 phenotypes.
This case-control study investigates whether body image is impaired in patients with hidradenitis suppurativa and whether disease severity, age at onset, disease duration, obesity, depression, and anxiety are linked to body image impairment.
This study examines the accuracy and clinical relevance of a newly developed scoring system for hidradenitis suppurativa severity.
This survey study uses clinical data from a set of self-administered, self-graded questionnaires to examine the correlation among resilience, depression, and health-related quality of life for patients with hidradenitis suppurativa.
This narrative review summarizes the diagnosis, epidemiology, and treatment of hidradenitis suppurativa, with an emphasis on advances in the last 5 years.
This case report describes the use of canakinumab to treat 2 patients with severe hidradenitis suppurativa.
This case-control study investigates the follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls.
This population-based analysis establishes standardized overall and sex- and age-specific prevalence estimates for hidradenitis suppurativa in the United States.
This Clinical Evidence Synopsis summarizes a Cochrane review assessing which treatments have been shown to be effective in randomized clinical trials for hidradenitis suppurativa in adults.
This study examines the prevalence of Firmicutes in bacterial cultures of purulent drainage from hidradenitis suppurativa lesions and explores its potential association with body mass index.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: